S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.05%) $0.927
USD/NOK
(0.25%) $10.87
USD/GBP
(0.06%) $0.793
USD/RUB
(-0.29%) $92.31

Realtime updates for Ondine Biomedical Inc. [OBI.L]

Exchange: LSE Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 11:45

-5.13% £ 9.25

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 11:45):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally...

Stats
Today's Volume 39 379.00
Average Volume 264 588
Market Cap 18.04M
EPS £-0.124 ( 2011-06-30 )
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -1.540
ATR14 £0 (0.00%)

Ondine Biomedical Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ondine Biomedical Inc. Financials

Annual 2022
Revenue: £638 000
Gross Profit: £287 000 (44.98 %)
EPS: £-0.110
Q2 2023
Revenue: £257 508
Gross Profit: £-25 872.00 (-10.05 %)
EPS: £-0.0244
Q4 2022
Revenue: £240 478
Gross Profit: £-60 120.00 (-25.00 %)
EPS: £-0.0355
Q2 2017
Revenue: £640 043
Gross Profit: £422 967 (66.08 %)
EPS: £-0.120

Financial Reports:

No articles found.

Ondine Biomedical Inc.

Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators